Meningitis-linked firm sold drugs without prescriptions: emails

BOSTON (Reuters) – The drug-mixing company at the heart of a deadly U.S. meningitis outbreak solicited bulk orders from physicians and failed to require proof of individual patient prescriptions as required under state regulations, emails to a customer show. Reuters reviewed more than a dozen emails …